Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02198235 · ClinicalTrials.gov registry record · Phase 1
Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)
A Phase 1 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT02198235 is a Phase 1 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 90 participants.
The verdict
NCT02198235, a Phase 1 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study looks at addition of medications to the local anesthetic for the nerve blockade.
Interventions
- DRUG Dexamethasone
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02198235
The ClinicalTrials.gov registry entry for NCT02198235 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT02198235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02198235 about?
NCT02198235 is a clinical study titled "Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)". This study looks at addition of medications to the local anesthetic for the nerve blockade.
What is the current status of trial NCT02198235?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2012-10. Estimated completion is 2014-02.
What interventions are being tested in trial NCT02198235?
The interventions under investigation include: Dexamethasone (DRUG), Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT02198235?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.